These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28258235)

  • 1. Antibiotic-non-antibiotic combinations for combating extremely drug-resistant Gram-negative 'superbugs'.
    Schneider EK; Reyes-Ortega F; Velkov T; Li J
    Essays Biochem; 2017 Feb; 61(1):115-125. PubMed ID: 28258235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymyxin B combinations with FDA-approved non-antibiotic phenothiazine drugs targeting multi-drug resistance of Gram-negative pathogens.
    Hussein M; Hu X; Paulin OKA; Crawford S; Tony Zhou Q; Baker M; Schneider-Futschik EK; Zhu Y; Li J; Velkov T
    Comput Struct Biotechnol J; 2020; 18():2247-2258. PubMed ID: 32952938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic adjuvants: an alternative approach to overcome multi-drug resistant Gram-negative bacteria.
    Liu Y; Li R; Xiao X; Wang Z
    Crit Rev Microbiol; 2019 May; 45(3):301-314. PubMed ID: 30985240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
    Tran TB; Velkov T; Nation RL; Forrest A; Tsuji BT; Bergen PJ; Li J
    Int J Antimicrob Agents; 2016 Dec; 48(6):592-597. PubMed ID: 27793510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial Peptide Novicidin Synergizes with Rifampin, Ceftriaxone, and Ceftazidime against Antibiotic-Resistant Enterobacteriaceae In Vitro.
    Soren O; Brinch KS; Patel D; Liu Y; Liu A; Coates A; Hu Y
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6233-40. PubMed ID: 26248380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of antibiotic resistance in the intensive care unit setting.
    Petrosillo N; Capone A; Di Bella S; Taglietti F
    Expert Rev Anti Infect Ther; 2010 Mar; 8(3):289-302. PubMed ID: 20192683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Importance of antibiotic combinations with ceftazidime and usefulness in the prevention of resistance].
    Gutmann L; Blériot JP
    Presse Med; 1988 Oct; 17(37):1904-7. PubMed ID: 2973582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination antibiotic therapy for empiric and definitive treatment of gram-negative infections: insights from the Society of Infectious Diseases Pharmacists.
    Boyd N; Nailor MD
    Pharmacotherapy; 2011 Nov; 31(11):1073-84. PubMed ID: 22026395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the antibiotic resistance crisis.
    Rossolini GM; Arena F; Pecile P; Pollini S
    Curr Opin Pharmacol; 2014 Oct; 18():56-60. PubMed ID: 25254623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combating multidrug-resistant Gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers.
    Lam SJ; O'Brien-Simpson NM; Pantarat N; Sulistio A; Wong EH; Chen YY; Lenzo JC; Holden JA; Blencowe A; Reynolds EC; Qiao GG
    Nat Microbiol; 2016 Sep; 1(11):16162. PubMed ID: 27617798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for the empirical management of infection in cancer patients with emphasis on the emergence of resistant gram-negative bacteria.
    Klastersky J; Georgala A
    Crit Rev Oncol Hematol; 2014 Dec; 92(3):268-78. PubMed ID: 25151213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
    Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C
    J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of antibiotic resistance in bacterial pathogens by oleanolic acid and ursolic acid.
    Kurek A; Nadkowska P; Pliszka S; Wolska KI
    Phytomedicine; 2012 Apr; 19(6):515-9. PubMed ID: 22341643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Novel Polymyxin-Like Antibiotics.
    Velkov T; Roberts KD
    Adv Exp Med Biol; 2019; 1145():343-362. PubMed ID: 31364086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance.
    Lee SY; Kuti JL; Nicolau DP
    Surg Infect (Larchmt); 2005; 6(3):283-95. PubMed ID: 16201938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caprylic acid and glyceryl trinitrate combination for eradication of biofilm.
    Rosenblatt J; Reitzel RA; Raad I
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1786-8. PubMed ID: 25534725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyxins: Mode of Action.
    Li Z; Velkov T
    Adv Exp Med Biol; 2019; 1145():37-54. PubMed ID: 31364070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City.
    Quale J; Shah N; Kelly P; Babu E; Backer M; Rosas-Garcia G; Salamera J; George A; Bratu S; Landman D
    Microb Drug Resist; 2012 Apr; 18(2):132-6. PubMed ID: 22196342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistant gram-negative infections.
    Fraimow H; Nahra R
    Crit Care Clin; 2013 Oct; 29(4):895-921. PubMed ID: 24094384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic resistance: how it arises, the current position and strategies for the future.
    Perry C; Hall C
    Nurs Times; 2009 Sep 15-21; 105(36):20-3. PubMed ID: 19835196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.